spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  metronidazole 

 HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Feb 2015
Galderma Announces Availability of Soolantra(R) (ivermectin) Cream, 1%
Biopharmaceuticals Dermatology FDA Product Launch
 HSMN NewsFeed - 3 Sep 2013
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 28 Apr 2010
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra(R) (lopinavir / ritonavir) for Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 1 Jun 2009
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week (DDW)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 Apr 2009
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 5 Aug 2008
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2007
Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 31 Jul 2007
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2007
Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2007
FDA Approves Tindamax(R) for Bacterial Vaginosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2007
Axcan Announces the U.S. Launch of PYLERA, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 11 Apr 2007
Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel(R) (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jan 2007
Galderma USA Introduces New Kit For Rosacea Treatment
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 9 Nov 2006
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Sep 2006
Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
Axcan Receives FDA Approval Letter for PYLERA'TM' -Formerly Known as HELIZIDE-, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 8 May 2006
Mission Pharmacal Completes Phase III Study of Tindamax(R) for the Treatment of Bacterial Vaginosis
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2006
Axcan submits FDA amendment to its new drug application for HELIZIDE
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 6 Mar 2006
Study Compares Once-daily Metronidazole 1% Gel to Twice-daily Azelaic Acid 15% Gel in the Treatment of Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Feb 2006
Oscient Pharmaceuticals Acquires Expanded Worldwide Rights to Lead Clinical Candidate Ramoplanin
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 19

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 19 additional stories matching:
metronidazole
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.